In vivo mapping of striatal neurodegeneration in Huntington's disease with Soma and Neurite Density Imaging
This study demonstrates that Soma and Neurite Density Imaging (SANDI) effectively detects Huntington's disease-related striatal neurodegeneration by revealing reduced soma density and increased soma size, which significantly correlate with motor impairment and striatal atrophy, positioning SANDI as a promising non-invasive biomarker for clinical trials.